New development in stem cell transplant for blood cancers set to change 40 years of standard practice
Medical Xpress
JUNE 16, 2025
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukemia significantly improves patient outcomes post-transplant, reducing the risk of the life-threatening complication of graft versus host disease (GVHD).
Let's personalize your content